The Medical Director Is Dead.
Live the Medical Director.
Why putting a physician’s name on a contract is no longer enough to govern modern healthcare
For decades, healthcare businesses could treat the Medical Director position almost like another box on the compliance checklist.
Find a physician.
Sign an agreement.
Put their name on the protocols.
Have them review a few charts.
Call them when something goes wrong.
Done.
Except healthcare doesn’t work like that anymore.
Care has escaped the four walls of the traditional medical practice.
Today we have virtual weight loss platforms treating patients across multiple states. Mobile IV companies sending clinicians into homes and hotels. Medical spas operating multiple locations. Telepsychiatry networks. Wound care groups. Remote monitoring programs. Compounding pharmacies shipping medications directly to patients.
And increasingly, we have software and artificial intelligence participating in decisions that used to belong exclusively to humans.
The Medical Director didn’t disappear.
The job became much bigger.
And I believe a significant portion of healthcare’s existing Medical Director infrastructure has not caught up.
A signature is not clinical governance
This was one of the central reasons I wrote The State of Modern Medical Directorship in America: 2026 Industry Report.
After more than 20 years working in healthcare operations and medical directorship, I’ve become increasingly interested in a simple question:
What makes a Medical Director actually capable of governing the clinical work performed under their authority?
Not what the contract says.
Not whether their name appears on the website.
Not whether someone can produce a signed agreement during an audit.
Can the physician actually govern?
That distinction matters.
A physician can have enormous responsibility on paper while having almost no practical ability to influence what is happening inside the organization.
They may not see the complaints.
They may not know a pharmacy changed.
They may not know a clinician’s license is approaching expiration.
They may not know that somebody changed a protocol.
They may not know a new AI tool was plugged into the workflow.
They may not have enough compensated time to review what they’re supposedly overseeing.
And sometimes they technically have the ability to make recommendations but no meaningful authority to stop something they believe is unsafe.
Calling that person the Medical Director doesn’t solve the problem.
It describes the problem.
The ACI Standard™
While developing the report, I wanted a simple framework for evaluating whether clinical governance actually exists.
I call it the ACI Standard™:
Authority × Capacity × Information = Effective Clinical Governance
These aren’t three nice things to have.
They depend on one another.
Authority
Can the physician actually intervene?
Can the Medical Director stop unsafe care?
Change a protocol?
Restrict clinical activity?
Escalate a serious concern?
If operations can simply ignore the Medical Director, the physician may have a title without meaningful authority.
Capacity
Does the physician actually have enough time and resources to perform the job?
A Medical Director overseeing several states, hundreds of clinicians and thousands of encounters cannot meaningfully govern the organization with a token amount of time every month.
Capacity includes protected time, compensation, administrative support, access to the right people and enough resources to investigate and act.
Information
Does the Medical Director know what is happening?
That means more than having EHR access.
Clinical governance requires information about outcomes, complaints, incidents, credentialing, protocol exceptions, pharmacies, laboratories, vendors, audits and regulatory changes.
A Medical Director who only discovers a problem after an adverse event isn’t governing prospectively.
They’re reconstructing history.
And that’s why I designed the relationship as multiplication rather than addition:
A × C × I
If any factor approaches zero, effective clinical governance approaches zero.
A physician with information and capacity but no authority cannot govern.
A physician with authority and information but no capacity cannot govern.
And a physician with authority and capacity but no information is effectively governing blind.
The ACI Standard™ is not a law, regulation, accreditation requirement or validated legal test.
It’s a framework I developed for asking a question healthcare organizations should probably be asking themselves before somebody else asks it for them:
Can our Medical Director actually govern this organization?
The Medical Director now governs infrastructure
There’s another misconception I think healthcare needs to abandon.
Medical directorship isn’t just physician supervision.
Modern clinical governance touches an entire operating system.
In the report, I identify 11 domains of Clinical Governance Infrastructure:
People.
Protocols.
Licenses.
Vendors.
Pharmacies.
Laboratories.
Technology.
Artificial intelligence.
Data.
Escalation.
Documentation.
Think about what happens when one of those sits completely outside clinical visibility.
A pharmacy changes how a medication is sourced.
A laboratory changes a testing process.
A clinician’s credential expires.
An employee begins using an unapproved AI tool.
A protocol gets copied from one state into another where the rules are different.
A patient complaint identifies a recurring safety issue but never reaches the physician responsible for clinical oversight.
The Medical Director can still be held responsible for a clinical system they never actually had the infrastructure to govern.
That’s the disconnect we need to fix.
Telehealth made the weakness impossible to ignore
Telehealth didn’t eliminate geography from medicine.
In many ways, it made geography more important.
The patient’s location matters.
The clinician’s license matters.
Scope of practice matters.
Prescribing authority matters.
Collaboration and supervision requirements matter.
Emergency procedures matter.
And those requirements can change when the patient crosses a state line.
The Interstate Medical Licensure Compact has made physician licensing substantially more efficient across participating jurisdictions, but it is not a national medical license.
Individual states still regulate the practice of medicine within their borders.
The same complexity exists with nurse practitioners and physician assistants.
The result is that a national healthcare company cannot responsibly operate from one generic clinical playbook.
It needs living state and service line matrices covering licensure, scope, delegation, prescribing and supervision.
That’s governance.
The MSO structure doesn’t magically solve clinical control
Another area receiving increased attention is the relationship between business operations and clinical judgment.
Corporate Practice of Medicine restrictions vary significantly by state, but the underlying question is fairly straightforward:
Who actually controls medicine?
An MSO can support technology, scheduling, billing, facilities, marketing and other nonclinical functions.
But a contract calling something an “MSO” doesn’t automatically establish clinical independence.
You have to look at what actually happens.
Who controls protocols?
Who makes prescribing decisions?
Who determines clinical necessity?
Who hires or disciplines clinicians for clinical performance?
Who controls patient records?
And what happens when the physician says no?
California made this conversation particularly relevant in 2026 with SB 351 and AB 1415, which imposed new restrictions involving private equity, hedge funds, MSOs and interference with professional clinical judgment.
The lesson extends beyond California.
Healthcare structure should be evaluated based on substance, not simply the names written across the organizational chart.
Then AI walked into the examination room
This may become the biggest change of all.
According to the AMA survey cited in my report, 81% of physicians reported professional use of AI in 2026, more than double the 38% measured in 2023.
Think about how quickly that happened.
AI can summarize notes.
Draft patient communications.
Flag clinical risks.
Assist with documentation.
Analyze data.
Recommend next steps.
And increasingly, it can influence diagnostic and prescribing decisions.
So who governs the algorithm?
I believe this becomes part of the Medical Director’s job.
Healthcare organizations will need to know which AI systems are approved, what they’re allowed to do, how their outputs are validated, when human review is mandatory, how model changes are tracked and what happens when the system is wrong.
That is why the ACI framework applies to algorithmic clinical work too.
Does the physician have the authority to stop use of an unsafe tool?
Do they have the capacity to evaluate and monitor it?
Do they receive the information necessary to know how it’s performing?
If not, we have recreated the paper Medical Director problem with software.
The future Medical Director isn’t supervising only humans
By 2030, I expect leading Medical Directors to be governing hybrid clinical systems.
Physicians.
Nurse practitioners.
Physician assistants.
Nurses.
Remote monitoring.
Laboratories.
Pharmacies.
Clinical software.
AI.
Multiple service lines.
Multiple states.
Multiple regulatory environments.
The organizations that win won’t necessarily be the organizations that automate the most.
They’ll be the ones that can answer:
What did we automate?
Why?
Who approved it?
How do we measure it?
When does a human intervene?
What happens when it fails?
That’s clinical governance.
So what should healthcare organizations do now?
Don’t start by rewriting the Medical Director contract.
Start by looking at reality.
Who is the accountable physician?
What exactly are they responsible for?
Can they stop unsafe care?
What information reaches them?
How frequently?
How much protected time do they have?
Which clinicians are operating under their governance?
Which states?
Which pharmacies?
Which laboratories?
Which vendors?
Which AI tools?
Which protocols?
What happens when something goes wrong?
And can you prove that the oversight you claim is actually happening?
The report includes a 90 day implementation blueprint built around exactly that process.
The first 30 days establish visibility.
The next 30 build controls.
The final 30 test whether those controls actually work.
Because compliance documentation that describes a system that doesn’t exist isn’t much of a defense.
Medical directorship isn’t disappearing. The paper version should.
I don’t believe the Medical Director is becoming less important.
I believe we’re moving toward the opposite.
As healthcare becomes more distributed, automated, virtual and complex, somebody still has to be clinically accountable for the system.
But that physician needs more than a title.
They need authority.
They need capacity.
They need information.
And they need infrastructure connecting those things to the clinical work happening in their name.
That’s what modern medical directorship needs to become.
Not physician rental.
Not signature collection.
Not a compliance ornament.
Clinical Governance Infrastructure built around real physician authority.
That is the future of the Medical Director.
And in many parts of healthcare, that future is already here.
AJ Pakpour is a healthcare entrepreneur, author and operations executive with more than 20 years of experience building healthcare businesses and operational systems across the United States. He is the originator of the ACI Standard™ and Clinical Governance Infrastructure framework and is affiliated with Doctor Staffers and The Business of Modern Medicine.
Read the complete research: The State of Modern Medical Directorship in America: 2026 Industry Report
👉 AJPakpour.com/medical-directorship-2026
If you’re building or expanding a healthcare practice and need help with medical directorship, clinical governance or practice strategy:
👉 Book a Strategy Session at AJPakpour.com
#MedicalDirector #ClinicalGovernance #HealthcareBusiness #HealthcareLeadership #AJPakpour
Comments
Post a Comment